0001179110-17-010227.txt : 20170707
0001179110-17-010227.hdr.sgml : 20170707
20170707165712
ACCESSION NUMBER: 0001179110-17-010227
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170705
FILED AS OF DATE: 20170707
DATE AS OF CHANGE: 20170707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCELERON PHARMA INC
CENTRAL INDEX KEY: 0001280600
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-9200
MAIL ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kumar Ravindra
CENTRAL INDEX KEY: 0001586835
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36065
FILM NUMBER: 17955741
MAIL ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2017-07-05
0
0001280600
ACCELERON PHARMA INC
XLRN
0001586835
Kumar Ravindra
128 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
SVP & Chief Scientific Officer
Common Stock
2017-07-05
4
M
0
937
7.12
A
96264
D
Common Stock
2017-07-05
4
S
0
937
32.00
D
95327
D
Option to Purchase Common Stock
7.12
2017-07-05
4
M
0
937
0
D
2022-12-12
Common Stock
937
0
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The options of registrant's common stock vested in equal quarterly installments over the first four years after the grant.
/s/ John D. Quisel, as attorney-in-fact for Ravindra Kumar
2017-07-07